Global Menopause Market
HealthcareServices

Global Menopause Market 2026–2030: Forecast Insights for Business Planning

Uncover key drivers, emerging technologies, and competitive movements shaping the menopause market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Menopause Market be in 2030 compared with 2026?

The menopause market size has demonstrated strong expansion in recent years. It is projected to increase from $18.78 billion in 2025 to $19.95 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to an aging female population, increased life expectancy among women, the widespread use of hormone replacement therapy, growing awareness of menopausal symptoms, and the expansion of women’s healthcare services.

The menopause market size is projected to expand considerably in the coming years. This market is anticipated to reach $26.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is driven by several factors, including a heightened demand for safer long-term treatments, the proliferation of digital health platforms dedicated to menopause, an amplified emphasis on women’s preventive health, broader availability of online pharmacies, and increased embrace of alternative and lifestyle-centric therapies. Key trends projected for this period involve an increasing uptake of non-hormonal menopause therapies, enhanced awareness and more proactive approaches to menopause management, a growing inclination towards dietary supplements and natural remedies, the broadening of personalized menopause care initiatives, and a greater need for solutions tailored to specific symptoms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp

What Drivers Are Guiding Growth Patterns In The Menopause Market?

The rise in evolving lifestyles is anticipated to boost the growth of the menopause market moving forward. An evolving lifestyle denotes shifts in how people live and make decisions that impact their health and wellness. During this natural biological stage, adjusting one’s lifestyle can help manage menopausal symptoms and improve overall health. Menopause offers an opportunity to modify lifestyle choices in several ways, including adopting a nutritious diet, exercising regularly, getting sufficient sleep, refraining from smoking and consuming excessive alcohol, and engaging in calming pursuits. For instance, in November 2023, a press release by Global Wellness Institution, a US-based organization, revealed that in 2022, the wellness economy constituted 5.6% of global economic output and is projected to expand to $8.5 trillion by 2027, showing an average annual growth rate of 8.6%. Consequently, the increasing trend of changing lifestyles is fueling the expansion of the menopause market.

Which Segments Are Driving Activity In The Menopause Market?

The menopause market covered in this report is segmented –

1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products

2) By Route Of Administration: Topical, Oral, Injectables

3) By Distribution Channel: Hospital, Retail, Online Pharmacies

4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Dietary Supplements: Herbal Supplements, Vitamins And Minerals, Phytoestrogens, Omega-3 Fatty Acids, Probiotics

2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants For Mood Swings, Sleep Aids, Pain Relievers

Which Trends Are Influencing The Performance And Direction Of The Menopause Market?

Leading companies in the menopause market are concentrating on developing innovative treatments, such as dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists, to provide hormone-free alternatives for vasomotor symptoms (hot flashes and night sweats) and enhance the quality of life for menopausal women. Dual neurokinin 1/neurokinin 3 receptor antagonists are oral pharmaceuticals designed to concurrently block both NK1 and NK3 receptors in the hypothalamus, thereby modulating the neuropeptide pathways responsible for thermoregulation and sweat responses and reducing the frequency and severity of hot flashes and associated sleep disturbances. For example, in October 2025, Bayer AG, a Germany-based pharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for Lynkuet (elinzanetant) 60 mg capsules. This product is the world’s first dual-NK1/NK3 receptor antagonist approved for treating moderate to severe hot flashes caused by menopause. Lynkuet offers once-daily bedtime dosing, demonstrated significant reductions in both the frequency and severity of hot flashes across three Phase III trials (OASIS 1/2/3), and utilizes a non-hormonal mechanism of action that expands treatment choices for women for whom hormone therapy is contraindicated.

Which Key Players Are Driving Competition In The Menopause Market?

Major companies operating in the menopause market are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., Serenity Pharmaceuticals LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Menopause Market?

North America was the largest region in the menopause market in 2025. The regions covered in the menopause market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Menopause Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13190&type=smp

Browse Through More Reports Similar to the Global Menopause Market 2026, By The Business Research Company

Homeopathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/homeopathy-global-market-report

Menopausal Hot Flashes Market Report 2026

https://www.thebusinessresearchcompany.com/report/menopausal-hot-flashes-global-market-report

Womens Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model